US Bancorp
IMA

US Bancorp’s ImageneBio Inc IMA Stock Holding History

US Bancorp’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18
Closed -$1.43K – 4049
2023
Q2 		$1.43K Hold
18
– – ﹤0.01% 3759
2023
Q1 		$752 Buy
+18
New +$827 ﹤0.01% 3907

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

US Bancorp's IMA Position: Q3 2023 in Review

US Bancorp sold out of ImageneBio Inc (IMA) in Q3 2023, closing a stake of 18 shares — an estimated $1.43K sold.

US Bancorp first reported a position in IMA in Q1 2023 and held it in 2 quarters. The position peaked at $1.43K in Q2 2023. 58 funds tracked by Wall St. Rank hold IMA as of Q3 2023.

  • US Bancorp reported no remaining ImageneBio Inc position as of Q3 2023 after selling out during the quarter.
  • US Bancorp sold 18 ImageneBio Inc shares in Q3 2023, an estimated $1.43K.
  • US Bancorp first reported a position in ImageneBio Inc in Q1 2023 and held it in 2 quarters.
  • US Bancorp's ImageneBio Inc position peaked at $1.43K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2023.

Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.